主要文章

　　1、Chen X, Li K, Liu Z, et al. Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC. Cancer Med. 2021;10:2286–2292.

　　2、Li X, Du W, Wang Y, Liu Z, Li K, Chen H, Liu R, Ma L, Zhang L, Dong Y, Che N, Gao M.Rapid diagnosis of tuberculosis meningitis by detecting Mycobacterium tuberculosis cell-free DNA in cerebrospinal fluid.American Journal of clinical pathology,153:126-130. IF:2.094

　　3、Tang Y, Che N, Yu Y, Gao Y, Shi H, Feng Q, Wei B, Ma L, Gao M, Ma J, Lin D. Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs.J Cancer Res Clin Oncol,146(2):407-416.IF:3.656.

　　4、Yang X, Che N, Duan H, Liu Z, Li K, Li H, Guo C, Liang Q, Yang Y, Wang Y, Song J, Du W, Chen Z, Wang Y, Zhang Y, Wang H, Chen X. Cell-free Mycobacterium tuberculosis DNA test in pleural effusion for tuberculous pleurisy: a diagnostic accuracy study.Clin Microbiol Infect,26(8):1089.e1-1089.e6. IF:7.117.

　　5、Dong Y, Zhou L, Zhao D, Li K, Liu Z, Che N, Liu H. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.Jpn J Clin Oncol,50(6):701-711. IF:1.914.

　　6、Ziguang Xu, Hongxia Li, Yujie Dong, Peng Cheng, Fang Luo, Shijun Fu, Min Gao, Lingfei Kong, Nanying Che. Incidence and PD-L1 Expression of MET 14 Skipping in Chinese Population: A Non-Selective NSCLC Cohort Study Using RNA-Based Sequencing.Oncotargets And Therapy,13:6245-6253.IF:3.337.

　　7、Shao L, Qiu C, Zheng L, Yang Y, Yang X, Liang Q, Zhang Y, Che N, Pang Y, Duan H. Comparison of diagnostic accuracy of the GeneXpert Ultra, and cell-free nucleic acid assay for tuberculous meningitis: a multicenter prospective study.Int J Infect Dis,S1201-9712(20)30513-0. IF:3.202.

　　8、Tao H, Shi L, Zhou A, Li H, Gai F, Huang Z, Che N, Liu Z.Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer.Lung Cancer,149:154-161. IF:4.702.

　　9、Tang Y, Che N, Yu Y, Gao Y, Shi H, Feng Q, Wei B, Ma L, Gao M, Ma J, Lin D. Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs. J Cancer Res Clin Oncol. 2020, 146(2):407-416.

　　10、Yang X, Che N, Duan H, Liu Z, Li K, Li H, Guo C, Liang Q, Yang Y, Wang Y, Song J, Du W, Chen Z, Wang Y, Zhang Y, Wang H, Chen X. Cell-free Mycobacterium tuberculosis DNA test in pleural effusion for tuberculous pleurisy: a diagnostic accuracy study. Clin Microbiol Infect. 2019, doi: 10.1016/j.cmi.2019.11.026. [Epub ahead of print]

　　11、DU Wei Li, SONG Jing, WANG Jian Guo, LIU Zi Chen, LI Kun, WANG Yu Xuan , DONG Yu Jie , CHE Nan Ying. Performance of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculosis by testing formalin-fixed paraffin-embedded tissues. Biomedical and Environmental Sciences, 2019, 32(12):922-925.

　　12、Dong Y, Zhou L, Zhao D, Li K, Liu Z, Che N, Liu H. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis. Jpn J Clin Oncol. 2020, doi: 10.1093/jjco/hyaa016. [Epub ahead of print]

　　13、Qu Y, Emoto K, Eguchi T, et al. Pathologic assessment after neoadjuvant chemotherapy for NSCLC: importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma. J Thorac Oncol. 2019, 14(3):482-493.

　　14、Ma Y, Che NY, Liu YH, et al. The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2019, 38(4):651-657.

　　15、Qu Y, Lin H, Zhang C, et al. Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort. Pathol Res Pract. 2019, 215(2):347-353.

　　16、Xuelian Li, Weili Du, et al. Rapid diagnosis of tuberculosis meningitis by detecting Mycobacterium tuberculosis cell-free DNA in cerebrospinal fluid.2019,American Journal of clinical pathology, 2020:153(1)：126-130.

　　17、Dong Y, Zhou Z, Wang J, et al. Origin of the T790M mutation and its impact on the clinical outcomes of patients with lung adenocarcinoma receiving EGFR-TKIs. Pathol Res Pract. 2019, 215(5):946-951.

　　18、Ji X, Che N, Lin R， et al. Efficient ten-gene analysis of NSCLC tissue samples by next-generation sequencing. Pathol Res Pract. 2019，215(5):1066-1070.

　　19、Han Y, Chen X, Huang S, Qin M, Liu Z, Che N. The application of Xpert Mycobacterium tuberculosis /rifampicin, quantitative Polymerase Chain Reaction and high resolution melting curve in the diagnosis of superficial lymph node TB. Curr Pharm Biotechnol.2019 20 (12): 1044-1054.

　　20、Bi Y,Qu Y, Zhang H, Feng R. Clinicopathological analysis of Large Cell Lung Carcinomas definitely diagnosed according to the New World Health Organization Criteria. Pathol Res Pract.2018,214(4):555-559.

　　21、Nanying Che, Yan Ma, Huabin Ruan, Lina Xu, Xueying Wang, Xinting Yang, Xiaohui Liu.Integrated semi-targeted metabolomics analysis reveals distinct metabolic dysregulation in pleural effusion caused by tuberculosis and malignancy. Clinica Chimica Acta. 2018, 477:81-88.

　　22、Che N, Yang X, Liu Z, Li K, Chen X. Rapid Detection of Cell-Free Mycobacterium tuberculosis DNA in Tuberculous Pleural Effusion. J Clin Microbiol. 2017, 55(5):1526-1532.

　　23、Che NY, Huang SJ, Ma Y, Han Y, Liu ZC, Zhang C, Mu J, Zhao D, Qu Y, Zhang HQ, Liu ZD, Xu SF. Comparison of Histological, Microbiological, and Molecular Methods in Diagnosis of Patients with TBLN Having Different Anti-TB Treatment Background. Biomed Environ Sci. 2017, 30(6):418-425.

　　24、Zhao D, Chen X, Qin N, Su D, Zhou L, Zhang Q, Li X, Zhang X, Jin M, Wang J. The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer. Sci Rep, 2017, 7:40374.

　　25、Qu Y, Zhao D, Mu J, Che N, Zhang C, Liu Z, Su D, Zhou L, Zhang H, Wei L. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study. Tumour Biol. 2016, 37(1):887-96.

　　26、Che N, Qu Y, Zhang C, Zhang L, Zhang H. Double staining of bacilli and antigen Ag85B improves the accuracy of the pathological diagnosis of pulmonary tuberculosis. J Clin Pathol. 2016, 69(7):600-6.

　　27、Ma Y, Liu YH, Zhang ZG, Wang L, Yang XW, Li CY, Che NY. Interleukin 8 Gene Polymorphisms Are Not Associated with Tuberculosis Susceptibility in the Chinese Population. Biomed Environ Sci. 2016, 29(2):158-61.

　　28、Hu AM, Zhao D, Zheng H, Wang QH, Lyu Y, Li BL. Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma.Chin Med J (Engl), 2016, 129(11):1377-1378.

　　29、Wei G, Mu J, Wang G, Huo F, Dong L, Li Y, Huang H. The reliability analysis of Xpert -positive result for smear-negative and culture-negative specimen collected from bone and joint tuberculosis suspects. Journal of Thoracic Disease, 2016, 8(6):1205-1209.

　　30、Dong YJ, Cai YR, Zhou LJ，Su D, Mu J, Chen XJ, Zhang L. Association between the histological subtype of lung adenocarcinoma, EGFR/ KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification. Oncology letters, 2016, 11(4):2552-2558.

　　31、Cai YR, Dong YJ, Wu HB, Liu ZC, Zhou LJ, Su D, Chen XJ, Zhang L, Zhao YL. Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas. Sci Rep, 2016, 6:23755.

　　32、Cai YR, Dong YJ, Wu HB, Yu DP，Zhou LJ, Su D, Zhang L, Chen XJ. Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. Oncology letters, 2016; 112(5):3312-3322.

　　33、Qu Y, Che N, Zhao D, Zhang C, Su D, Zhou L, Zhang L, Wang C, Zhang H, Wei L. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma. Tumour Biol. 2015, 36(8):6417-24.